S. Howard

发表

Differential In Vivo Activities of Anidulafungin, Caspofungin, and Micafungin against Candida glabrata Isolates with and without FKS Resistance Mutations

M. Arendrup, D. Perlin, R. H. Jensen, 2012, Antimicrobial Agents and Chemotherapy.

Validation of an Assay for Voriconazole in Serum Samples Using Liquid Chromatography-Tandem Mass Spectrometry

B. Keevil, D. Denning, C. Moore, 2004, Therapeutic drug monitoring.

Adverse reactions to voriconazole.

B. Keevil, D. Denning, C. Moore, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Fungal contamination of bedding

A. Woodcock, A. Custovic, A. Woodcock, 2006, Allergy.

An outbreak of Phialemonium infective endocarditis linked to intracavernous penile injections for the treatment of impotence.

G. Rahav, M. Feinberg, A. Zelazny, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cryptic Species and Azole Resistance in the Aspergillus niger Complex

D. Denning, J. Varga, P. Bowyer, 2011, Antimicrobial Agents and Chemotherapy.

Interrogation of Related Clinical Pan-Azole-Resistant Aspergillus fumigatus Strains: G138C, Y431C, and G434C Single Nucleotide Polymorphisms in cyp51A, Upregulation of cyp51A, and Integration and Activation of Transposon Atf1 in the cyp51A Promoter

G. Robson, D. Denning, M. Anderson, 2011, Antimicrobial Agents and Chemotherapy.

Toxicodynamics of itraconazole: implications for therapeutic drug monitoring.

D. Denning, C. Moore, S. Howard, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Major variations in Aspergillus fumigatus arising within aspergillomas in chronic pulmonary aspergillosis

D. Denning, M. Anderson, M. Anderson, 2013, Mycoses.

Impact of Bolus Dosing versus Continuous Infusion of Piperacillin and Tazobactam on the Development of Antimicrobial Resistance in Pseudomonas aeruginosa

M. Neely, S. Howard, J. Goodwin, 2013, Antimicrobial Agents and Chemotherapy.

A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility

M. Arendrup, K. Fuursted, H. Johansen, 2011, European Journal of Clinical Microbiology & Infectious Diseases.

Frequency and Evolution of Azole Resistance in Aspergillus fumigatus Associated with Treatment Failure

D. Denning, M. Fisher, M. Anderson, 2009, Emerging infectious diseases.

Rate of cyp51A mutation in Aspergillus fumigatus among lung transplant recipients with targeted prophylaxis.

S. Keshavjee, T. Mazzulli, S. Richardson, 2015, The Journal of antimicrobial chemotherapy.

Establishing In Vitro-In Vivo Correlations for Aspergillus fumigatus: the Challenge of Azoles versus Echinocandins

M. Arendrup, D. Perlin, C. Lass‐Flörl, 2008, Antimicrobial Agents and Chemotherapy.

Disseminated Candidiasis Caused by Candida albicans with Amino Acid Substitutions in Fks1 at Position Ser645 Cannot Be Successfully Treated with Micafungin

M. Arendrup, P. Warn, D. Perlin, 2011, Antimicrobial Agents and Chemotherapy.

Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009.

D. Denning, P. Bowyer, C. Moore, 2010, The Journal of antimicrobial chemotherapy.

Posaconazole: The Case for Therapeutic Drug Monitoring

S. Howard, W. Hope, T. Felton, 2012, Therapeutic drug monitoring.

Anidulafungin for Neonatal Hematogenous Candida Meningoencephalitis: Identification of Candidate Regimens for Humans Using a Translational Pharmacological Approach

D. Benjamin, M. Cohen-Wolkowiez, T. Walsh, 2011, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics and pharmacodynamics of posaconazole for invasive pulmonary aspergillosis: clinical implications for antifungal therapy.

P. Warn, J. Majithiya, S. Howard, 2011, The Journal of infectious diseases.

Azole resistance in allergic bronchopulmonary aspergillosis and Aspergillus bronchitis.

D. Denning, S. Howard, A. Pasqualotto, 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

zole-resistance in Aspergillus: Proposed nomenclature and breakpoints

D. Denning, W. Melchers, P. Verweij, 2009 .

Antifungal Therapeutic Drug Monitoring for Invasive Aspergillosis

S. Howard, W. Hope, 2009 .

Pharmacokinetics and Pharmacodynamics of Amphotericin B Deoxycholate, Liposomal Amphotericin B, and Amphotericin B Lipid Complex in an In Vitro Model of Invasive Pulmonary Aspergillosis

G. Jensen, T. Walsh, J. Majithiya, 2010, Antimicrobial Agents and Chemotherapy.

Pharmacodynamics of Itraconazole against Aspergillus fumigatus in an In Vitro Model of the Human Alveolus: Perspectives on the Treatment of Triazole-Resistant Infection and Utility of Airway Administration

P. Warn, A. Jeans, S. Howard, 2012, Antimicrobial Agents and Chemotherapy.

In vitro model of invasive pulmonary aspergillosis in the human alveolus.

S. Howard, W. Hope, L. Gregson, 2012, Methods in molecular biology.

Pharmacodynamics of voriconazole in a dynamic in vitro model of invasive pulmonary aspergillosis: implications for in vitro susceptibility breakpoints.

M. Arendrup, P. Warn, A. Jeans, 2012, The Journal of infectious diseases.

Derivation of an In Vivo Drug Exposure Breakpoint for Flucytosine against Candida albicans and Impact of the MIC, Growth Rate, and Resistance Genotype on the Antifungal Effect

David W. Denning, Miki Kasai, Thomas J. Walsh, 2006, Antimicrobial Agents and Chemotherapy.

Multi-azole resistance in Aspergillus fumigatus.

D. Denning, D. Perlin, Steven Park, 2006, International journal of antimicrobial agents.

Mechanisms of Antifungal Drug Resistance.

L. Cowen, P. D. Rogers, D. Perlin, 2015, Cold Spring Harbor perspectives in medicine.

Pharmacokinetics and Pharmacodynamics of Anidulafungin for Experimental Candida Endophthalmitis: Insights into the Utility of Echinocandins for Treatment of a Potentially Sight-Threatening Infection

P. Warn, S. Howard, J. Goodwin, 2012, Antimicrobial Agents and Chemotherapy.

Flucytosine therapeutic monitoring: 15 years experience from the UK.

D. Denning, C. Moore, S. Howard, 2007, The Journal of antimicrobial chemotherapy.

EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents.

M. Arendrup, J. Guinea, M. Cuenca‐Estrella, 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Isolation, identification and susceptibility of Pyrenochaeta romeroi in a case of eumycetoma of the foot in the UK.

D. Denning, P. Bowyer, S. Howard, 2009, International journal of antimicrobial agents.

Pharmacokinetics and Pharmacodynamics of Fluconazole for Cryptococcal Meningoencephalitis: Implications for Antifungal Therapy and In Vitro Susceptibility Breakpoints

J. Perfect, T. Harrison, P. Warn, 2013, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics and Pharmacodynamics of Fluconazole For

J. Perfect, T. Harrison, P. Warn, 2013 .

Efficacy of an Abbreviated Induction Regimen of Amphotericin B Deoxycholate for Cryptococcal Meningoencephalitis: 3 Days of Therapy Is Equivalent to 14 Days

J. Perfect, Werner Müller, T. Harrison, 2014, mBio.

Pharmacodynamics of liposomal amphotericin B and flucytosine for cryptococcal meningoencephalitis: safe and effective regimens for immunocompromised patients.

J. Perfect, M. Neely, T. Harrison, 2013, The Journal of infectious diseases.

In Vitro Susceptibility of Aspergillus fumigatus to Isavuconazole: Correlation with Itraconazole, Voriconazole, and Posaconazole

C. Moore, M. Richardson, S. Howard, 2013, Antimicrobial Agents and Chemotherapy.

Determination of Isavuconazole Susceptibility of Aspergillus and Candida Species by the EUCAST Method

M. Arendrup, M. Cuenca‐Estrella, C. Lass‐Flörl, 2013, Antimicrobial Agents and Chemotherapy.

Aspergillus Species and Other Molds in Respiratory Samples from Patients with Cystic Fibrosis: a Laboratory-Based Study with Focus on Aspergillus fumigatus Azole Resistance

M. Skov, M. Arendrup, E. Mellado, 2011, Journal of Clinical Microbiology.

Acquired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection.

M. Arendrup, S. Howard, 2011, Medical mycology.

EUCAST Testing of Isavuconazole Susceptibility in Aspergillus: Comparison of Results for Inoculum Standardization Using Conidium Counting versus Optical Density

M. Arendrup, M. Cuenca‐Estrella, C. Lass‐Flörl, 2014, Antimicrobial Agents and Chemotherapy.

Multi-Resistant Aspergillosis due to Cryptic Species

S. Howard, 2014, Mycopathologia.

Clinical utility of micafungin: pharmacokinetics, dosing, use in special populations and drug interactions

S. Howard, W. Hope, T. Felton, 2012 .

Combination of Voriconazole and Anidulafungin for Treatment of Triazole-Resistant Aspergillus fumigatus in an In Vitro Model of Invasive Pulmonary Aspergillosis

P. Warn, A. Jeans, S. Howard, 2012, Antimicrobial Agents and Chemotherapy.

In vitro susceptibility of non-Aspergillus allergenic fungal species to azoles.

D. Denning, C. Moore, S. Howard, 2009, The Journal of antimicrobial chemotherapy.

Development of Novel PCR Assays To Detect Azole Resistance-Mediating Mutations of the Aspergillus fumigatus cyp51A Gene in Primary Clinical Samples from Neutropenic Patients

W. Hofmann, D. Buchheidt, S. Howard, 2012, Antimicrobial Agents and Chemotherapy.

Interrogation of related clinical pan-azole resistant Aspergillus fumigatus strains – G138C, Y431C and G434C SNPs in cyp51A, Upregulation of cyp51A and integration and activation of transposon Atf1 into cyp51A promoter.

G. Robson, D. Denning, M. Anderson, 2011 .

Pharmacodynamics of Echinocandins against Candida glabrata: Requirement for Dosage Escalation To Achieve Maximal Antifungal Activity in Neutropenic Hosts

P. Warn, D. Perlin, A. Alastruey‐Izquierdo, 2011, Antimicrobial Agents and Chemotherapy.

Incidence and predictors of bulbar palsy after surgery for acoustic neuroma.

D. Duane, S. Howard, M. Kraayenbrink, 1997, Journal of neurosurgical anesthesiology.

An invertebrate model to evaluate virulence in Aspergillus fumigatus: the role of azole resistance.

E. Mellado, M. Cuenca‐Estrella, S. Howard, 2014, Medical mycology.